RCMECredit materiality pre-analysisIncludes illustrative values
Analytical aid.Not a rating or rating recommendation. Public data only.
Amgen
CIK
0000318154
SIC
2836
Event
8-K Item 1.05 · cyber incident
Identified
Needs analyst input
Filed
2026-07-31
Audit trailOpen memo

Disclosure pass · scored on the day of the 8-K

Credit materiality by dimension

Re-scored as a new audit trail row when the next 10-Q states the cost. The first score is never edited.

Overall materiality

Moderate

The overall tier is the highest of Financial Risk, Business Risk and the Liquidity gate. Governance evidence can only raise it. There is no weighted average. scoring_rules.md 4.5scoring_rules.md 4.6

Low · 0 days ModerateBase · 0 days ModerateHigh · 0 days Moderate

Financial risk

FFO to debt and debt to EBITDA, before and after the shock, against S&P published bands.

Moderate
FFO to debt12.9%Verifiedpre-event
Debt to EBITDA3.83xVerifiedpre-event
Pre-eventAfter shock, high caseWithin 10% of a band boundary

Corporate Methodology Table 17, standard volatility Corporate Methodology Table 17

Why

  • Low (0 days): FFO to debt 12.9% to 12.9%, stays in the 12% to 20% band. 7.5% from the 12% boundary, inside the 10% borderline zone.
  • Low (0 days): Debt to EBITDA 3.83x to 3.83x, stays in the 3x to 4x band. 4.2% from the 4x boundary, inside the 10% borderline zone.
  • Base (0 days): FFO to debt 12.9% to 12.9%, stays in the 12% to 20% band. 7.5% from the 12% boundary, inside the 10% borderline zone.
  • Base (0 days): Debt to EBITDA 3.83x to 3.83x, stays in the 3x to 4x band. 4.2% from the 4x boundary, inside the 10% borderline zone.
  • High (0 days): FFO to debt 12.9% to 12.9%, stays in the 12% to 20% band. 7.5% from the 12% boundary, inside the 10% borderline zone.
  • High (0 days): Debt to EBITDA 3.83x to 3.83x, stays in the 3x to 4x band. 4.2% from the 4x boundary, inside the 10% borderline zone.

Business risk

Operational status, share of earnings in the affected unit, outage length, data type.

Moderate
ScenarioDriverTier
LowPHI exposed outside data-intensive sectors (pharma devices).Moderate
BasePHI exposed outside data-intensive sectors (pharma devices).Moderate
HighPHI exposed outside data-intensive sectors (pharma devices).Moderate
Affected unit share
1.0 Derived single reportable segment: share 1.0
Data types
PHI Derived
Third-party impact
Needs analyst input

Why

  • All scenarios: PHI exposed outside data-intensive sectors (pharma devices).

Liquidity gate

Sources over uses for 12 months after the event cost, with a 15% EBITDA stress.

Low
Gate inputs (USD m). FFO after the event and the event cost are computed per scenario.
InputUSD mSource
Cash (source)9,129DerivedXBRL FY2025 (2025-01-01 to 2025-12-31)
Undrawn committed facilities, beyond 12 months (source)6,857n/a
Contracted asset sales (source)0n/a
Working capital change, 12 months (source)(381)n/a
Debt maturing in 12 months (use)4,571VerifiedXBRL FY2025 (2025-01-01 to 2025-12-31)
Capex (use)1,858DerivedXBRL FY2025 (2025-01-01 to 2025-12-31)
Contracted acquisitions (use)0n/a
Shareholder distributions (use)5,124n/a

Governance evidence

Flags that can only raise the overall tier, never lower it.

No flags in this pass

Why

  • All scenarios: no flags, overall tier moderate.

Outage scenarios

lost EBITDA = EBITDA × affected share × disruption fraction × days / 365
MeasurePre-eventLow · 0 daysBase · 0 daysHigh · 0 days
Lost EBITDA (USD m)n/a0Derived0Derived0Derived
FFO to debt12.9%Verified12.9%Verified12.9%Verified12.9%Verified
Debt to EBITDA3.83xVerified3.83xVerified3.83xVerified3.83xVerified
Ratio band movedn/aNoNoNo
Business risk tiern/aModerateModerateModerate
Overall tiern/aModerateModerateModerate

Financial context, FY2025 (USD m)

As-reported proxies. S&P adjustments not applied.

DerivedVerified
MetricUSD mProvenanceXBRL tags or formula
EBITDA14,247DerivedDerivedOperatingIncomeLoss + DepreciationDepletionAndAmortization
Debt54,604DerivedDerivedCommercialPaper + LongTermDebtCurrent + LongTermDebtNoncurrent
FFO7,047DerivedDerivedOperatingIncomeLoss + DepreciationDepletionAndAmortization + InterestPaid + IncomeTaxesPaidNet
CFO9,958VerifiedVerifiedNetCashProvidedByUsedInOperatingActivities
FOCF8,100DerivedDerivedNetCashProvidedByUsedInOperatingActivities + PaymentsToAcquirePropertyPlantAndEquipment
DCF2,976DerivedDerivedNetCashProvidedByUsedInOperatingActivities + PaymentsToAcquirePropertyPlantAndEquipment + PaymentsOfDividendsCommonStock + PaymentsForRepurchaseOfCommonStock
Cash interest2,900VerifiedVerifiedInterestPaid
Operating leases (shown separately)831VerifiedVerifiedOperatingLeaseLiability